PROFARMA (PFRM3) Main Indicators
Basic Data - PFRM3
| Company | PROFARMA |
| Corporate Name | PROFARMA DISTRIB PROD FARMACEUTICOS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Profarma atua na distribuição de produtos farmacêuticos. higiene pessoal e cosméticos. nos mais populosos estados brasileiros. |
| Share | PFRM3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 7.00 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.60 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 11/21/2024 | |
Relative Prices - PFRM3
| Price/Earnings | 8.07 |
| Price/SBV | 0.65 |
| Price/Net Sales | 0.09 |
| Price/CFO | 1.85 |
| Price/FCF | 2.31 |
| Price/Total Assets | 0.17 |
| Price/EBIT | 2.86 |
| Price/Working Capital | 0.82 |
| Price/NCAV | -0.32 |
| EV/EBIT | 4.55 |
| EV/EBITDA | 2.96 |
| EV/Net Sales | 0.15 |
| EV/CFO | 2.94 |
| EV/FCF | 3.67 |
| EV/Total Assets | 0.27 |
| Company Market Cap | R$ 866.69 M |
| Enterprise Value | R$ 1.38 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 7.00 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 5.51% |
| Updated 11/21/2024 | |
Income Statement - PFRM3
| Net Revenue | R$ 9.34 B |
| Gross Result | R$ 1.44 B |
| EBIT | R$ 303.28 M |
| Depreciation and Amortization | - R$ 162.69 M |
| EBITDA | R$ 465.97 M |
| Net Profit | R$ 107.45 M |
| Net Profit/Share | R$ 0.87 |
| Updated 10/30/2024 | |
| Net Revenue | R$ 2.60 B |
| Gross Result | R$ 395.65 M |
| EBIT | R$ 98.84 M |
| Depreciation and Amortization | - R$ 42.78 M |
| EBITDA | R$ 141.62 M |
| Net Profit | R$ 49.02 M |
| Profit/Share | R$ 0.40 |
| Updated 10/30/2024 | |
Price and Volume Behavior - PFRM3
| Lowest Price 52 weeks | R$ 4.48 |
| Highest Price 52 weeks | R$ 7.71 |
| Variation 2024 | 31.58% |
| Variation 1 year | 47.32% |
| Variation 2 years(total) | 132.24% |
| Variation 2 years(yearly) | 52.22% |
| Variation 3 years(total) | 56.53% |
| Variation 3 years(yearly) | 16.09% |
| Variation 4 years(total) | 61.72% |
| Variation 4 years(yearly) | 12.77% |
| Variation 5 years(total) | 105.35% |
| Variation 5 years(yearly) | 15.46% |
| Average Daily Volume (3 months) | R$ 1.55 M |
| Updated 11/21/2024 | |
Returns and Margins - PFRM3
| Return on Initial Tangible Capital | 10.95% |
| Return on Initial Invested Capital | 11.16% |
| Pre-Tax Return on Initial Tangible Capital | 16.59% |
| Pre-Tax Return on Initial Invested Capital | 16.91% |
| Return on Initial Shareholder´s Equity | 8.52% |
| Return on Initial Asset | 2.29% |
| Gross Margin | 15.40% |
| Net Margin | 1.15% |
| EBIT Margin | 3.25% |
| EBITDA Margin | 4.99% |
| Initial Asset Turnover | 1.99 |
| Financial Leverage | 3.82 |
| Liabilities/Net Worth | 2.82 |
| Net Debt/EBITDA | 1.10 |
| Updated 10/30/2024 | |
Balance Sheet - PFRM3
| Cash and Cash Equivalents | R$ 231.28 M |
| Total Assets | R$ 5.12 B |
| Short-Term Debt | R$ 245.12 M |
| Long-Term Debt | R$ 498.17 M |
| Gross Debt | R$ 743.29 M |
| Net Debt | R$ 512.01 M |
| Shareholder´s Equity | R$ 1.34 B |
| Share Book Value | R$ 10.82 |
| Common Shares | 123,813,000 |
| Preferred Shares | 0 |
| Total | 123,813,000 |
| Common Shares in Treasury | 1,202,000 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,202,000 |
| Common Shares (Except Treasury) | 122,611,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 122,611,000 |
| Updated 10/30/2024 | |
Cash Flow - PFRM3
| Operating Cash Flow | R$ 468.75 M |
| Cash Flow from Investments | - R$ 126.87 M |
| Financing Cash Flow | - R$ 288.64 M |
| Increase (Reduction) in Cash and Equivalents | R$ 53.25 M |
| Updated 10/30/2024 | |
| Operating Cash Flow | R$ 352.22 M |
| Cash Flow from Investments | - R$ 36.21 M |
| Financing Cash Flow | - R$ 239.82 M |
| Increase (Reduction) in Cash and Equivalents | R$ 76.19 M |
| Updated 10/30/2024 | |
Experimental - PFRM3
| CAPEX 3 months | - R$ 26.14 M |
| Free Cash Flow 3 months | R$ 326.08 M |
| CAPEX 12 months | - R$ 92.92 M |
| Free Cash Flow 12 months | R$ 375.83 M |
| Updated 10/30/2024 | |